SingleTimeMicroneedles
Developer of a transdermal microneedle patch platform designed for single-application, multi-dose and time-release delivery of drugs, vaccines, and supplements. The platform emphasizes thermal stability to reduce cold-chain requirements, dissolving microneedle delivery to avoid sharps waste, and adaptable formulations for human, animal, and nutraceutical applications. Research, preclinical results, and academic collaborations are highlighted as supporting evidence.
Industries
Nr. of Employees
small (1-50)
SingleTimeMicroneedles
Farmington, Connecticut, United States, North America
Products
Transdermal microneedle patch platform
A single-application patch platform that delivers drugs, vaccines, or supplements via dissolving microneedles with programmable multi-dose/time-release profiles and thermal-stable formulations suitable for human, veterinary, and nutraceutical applications.
Transdermal microneedle patch platform
A single-application patch platform that delivers drugs, vaccines, or supplements via dissolving microneedles with programmable multi-dose/time-release profiles and thermal-stable formulations suitable for human, veterinary, and nutraceutical applications.
Expertise Areas
- Transdermal microneedle systems
- Controlled-release delivery
- Thermal stabilization of vaccines and biologics
- Vaccine delivery for human and animal health
Key Technologies
- Dissolving microneedle arrays
- Programmable/multi-burst release systems
- Thermal stabilization via excipient/formulation
- Transdermal formulation development